• Selecting your portfolio and the market- Staying dynamic for growth with future opportunities

• Innovation and focus on R&D to stay ahead

• Keeping manufacturing processes agile with core focus on quality & patient

  centricity

• AI & Digital to help with process development and manufacturing

• Including Sustainability in your manufacturing 

   

  Moderated By: Dr.Mahesh Bhalgat, CEO & MD, Veeda Clinical Research Limited

   

  Panelists:

  Anil Matai, Director General, OPPI India

  Atul Shastri, President Operations, Eugia Pharma Specialities

  Dr.Tathagata Dutta, President & Chief Technology Officer, Jodas Expoim

  Abhay Srivastava, President Operations, Mankind Pharma

  Prof. Ravichandran, Director, NIPER- Kolkata

  Yugal Sikri, Managing Director, RPG Lifesciences
  

• Cost effective therapies and manufacturing to our leverage

• Government Policies and funding that support Indian Pharma & Biopharma

  Sectors

• Keeping quality and compliance at the core

• Forging Partnerships and alliances towards the goal 

   

  Dr.Rhonda Duffy, Chief Operating Officer, Biocon Biologics
  

• Understanding and mapping the advantages of Industry 4.0 technologies e.g., Process Automation, IoT, digital twins to optimize and streamline manufacturing and other value chain operations
• Understanding compliance with evolving global standards
• Cultivating a talent pool of digital champions 

Panelists:

• Narendra Saini, Chief Digital & Data Officer, Lupin
• Prudhvi Teja, Principal & Head DPEx, Dr.Reddys
• Dr.Mandar Ghatnekar, Global Head IT & Digital Transformation, Biocon
• Dheeraj Sinha, Executive Vice President and Chief Information Officer, Sunpharma 

• Potential of biosimilars in developing economics

• Understanding biosimilars research

• Using curated knowledge to accelerate biosimilar discoveries 
   

  Dr. Dennis McCullough – Vice President, Global Sales, CAS

• Continuous investment in R&D exploring new candidates & processes
• Developing high quality biosimilar with cost-effective manufacturing processes
• Analytical expertise for characterization and comparability
• Staying compliant with good QA/ QC practices

Speaker: Dr. Sanjeev Gupta, Sr. Vice President - Advanced Biotech Lab, IPCA Labs 

• Sustainable business practices in fluoropolymer business

• GFL's industry contribution and presence in major “Corrosive Applications” in

  Pharmaceuticals etc

• Use and benefits of high-performance polymers like PTFE, PFA and PVDF

  specially in “Lining and coating applications” across various Pharmaceuticals, CPI

  and allied industries

• Value & Pump Solution Case study -Cost effective Fluoropolymer solutions for

  handling of corrosive fluids and chemicals

• New Applications – Use of fluoropolymers in Roto lining & Coating applications- Case study 

   

  Raxit Mansinh Rodiya, Sr. Manager Application Dev. and Marketing, Gujarat Fluorochemicals 

• Embracing a Quality by Design approach with proactive risk management
• Building a robust quality management system
• Fostering a culture of compliance
• Digitalization to help quality control and assurance

Moderated By:

Subhrangshu Chaudhury, Vice President & Head of Quality, Centaur Pharmaceuticals

Panelists:

• Meenakshi Jain, Head, Regulatory Generics Development, Sandoz,
• India Matruprasad Priyadarshi, Senior Director- Regions & Program Operations & General Manager – South Asia, USP-India
• Swati Kapoor, Quality Head, Takeda India

Dr.Shubhadeep Sinha, Senior Vice-President- Development, Hetero